Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GEN ILAC) aktie
GENIL.IS
GEN ILAC
Market Cap
$38,930,661,376
Om Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi (GEN ILAC) aktie
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. In addition, it manufactures, trades, imports and exports of all kinds of human medicines and health products. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Selskabsinformation
06520 Çankaya, Turkey
Analytikernes aktieanbefalinger
Denne oversigt giver et hurtigt indblik i, hvordan analytikere vurderer aktiens potentiale baseret på deres seneste analyser og kursmål.